potentially

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Source Node:
Time Stamp: April 15, 2024 1:26 PM - Modified On: April 15, 2024 - Published By:
Source Cluster:
Republished By Plato

  Company is targeting pancreatic cancer pain with advanced nerve detection and treatment technology New York, March 12, 2024 - (Plato Data) - Benzinga has published a new article on Autonomix Medical Inc. (NASDAQ: AMIX), featuring the company's groundbreaking approach to peripheral nervous system (PNS) disorders. The Benzinga article delves into the critical role of the PNS in human health and highlights how Autonomix Medical is pioneering with its catheter-based microchip sensing array technology. The article provides a comprehensive look at how Autonomix Medical is redefining treatment protocols for nerve-related

Analyzing Token Sale Models

Source Node:
Time Stamp: February 20, 2024 1:29 PM - Modified On: February 20, 2024 - Published By:
Source Cluster:
Republished By Plato

Note: I mention the names of various projects below only to compare and contrast their token sale mechanisms; this should NOT be taken as an endorsement or criticism of any specific project as a whole. It's entirely possible for any given project to be total trash as a whole and yet still have an awesome token sale model. The last few months have seen an increasing amount of innovation in token sale models. Two years ago, the space was simple: there were capped sales, which sold a fixed number of

Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries

Source Node:
Time Stamp: February 2, 2024 2:30 PM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

  New York, Feb 2, 2024 - (Plato Data)- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and developing high-potential marketed drugs and development-stage drug candidates in-house and through its subsidiary partner companies, has announced multiple new milestones to start 2024 with a bang. Avenue Therapeutics Finalizes Phase 3 Study for IV Tramadol with FDA Avenue Therapeutics, a subsidiary of Fortress Bio, has reached a significant milestone in its quest to introduce new therapies for neurologic diseases. The company

A Note On Charity Through Marginal Price Discrimination

Source Node:
Time Stamp: February 2, 2024 11:17 AM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

Vitalik Buterin via the Vitalik Buterin Blog Updated 2018-07-28. See end note. The following is an interesting idea that I had two years ago that I personally believe has promise and could be easily implemented in the context of a blockchain ecosystem, though if desired it could certainly also be implemented with more traditional technologies (blockchains would help get the scheme network effects by putting the core logic on a more neutral platform). Suppose that you are a restaurant selling sandwiches, and you ordinarily sell sandwiches for $7.50. Why did

Bozo.Finance. A Groundbreaking NFTxTOKEN Solution Revolutionizing Decentralized Finance.

Source Node:
Time Stamp: February 1, 2024 10:46 AM - Modified On: February 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Bozo.Finance / Bozo Hybrid In an innovative leap forward for the DeFi space, Bozo Hybrid announces the launch of its revolutionary platform - a first-of-its-kind NFTxTOKEN hybrid that is reshaping the landscape of liquidity and asset interchangeability. The Game-Changing Innovation of Bozo HYBRID Bozo HYBRID is not just another project in the blockchain space. It represents a paradigm shift, a true DeFi 2.0 model, by integrating non-fungible tokens (NFTs) with fungible tokens ($bozo tokens) to create a two-way liquidity portal. This hybrid approach is a breakthrough in the market,

Unveiling the Inaugural Global Protocol Report: A Comprehensive Analysis of Blockchain Protocols that is Poised to Aid WEB3 Decisions

Source Node:
Time Stamp: January 22, 2024 4:40 AM - Modified On: January 22, 2024 - Published By:
Source Cluster:
Republished By Plato

Crypto Oasis, Crypto Valley, the DLT Science Foundation and Inacta Ventures Join Forces in a Groundbreaking Initiative that Will Help Navigate the Blockchain Trilemma Highlights: The report has unprecedented transparency and clarity, granular insights, and an evolving analysis of DLT protocol attributes. It will help industry experts and novices gain foundational knowledge on DLT concepts, WEB3 ecosystem infrastructure, the evolution of the Blockchain landscape, and the role of capital, talent, infrastructure, and regulations in WEB3 innovation. The Global Protocol Report introduces a comprehensive framework for assessing the maturity of DLT

From Dominance to Compliance

Source Node:
Time Stamp: December 3, 2023 1:05 PM - Modified On: December 3, 2023 - Published By:
Source Cluster:
Republished By Plato

Last Tuesday saw Binance settle its long-running legal disputes with several U.S. government agencies, including the Department of Justice (DoJ), the Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN), the Office of Foreign Assets Control (OFAC), and the U.S. Commodity Futures Trading Commission (CFTC). However, they failed to reach an agreement with the Securities and Exchange Commission (SEC) regarding their pending charges. As part of the settlement, Binance has agreed to pay an eye-popping fine of $4.3 billion. Furthermore, Changpeng Zhao (CZ), the CEO of Binance, will step down

The Collision of Titans: AI and Web3

Source Node:
Time Stamp: September 4, 2023 12:28 PM - Modified On: September 4, 2023 - Published By:
Source Cluster:
Republished By Plato

Over the past decade, two titans have emerged from the tech realm, each promising to redefine the very fabric of our global infrastructure - Artificial Intelligence (AI) and Web3. But what happens when these two forces converge? Are we on the brink of a new digital renaissance or a potentially uncharted dystopia? Consider this: AI is, at its core, the embodiment of advanced logic and decision-making, a machine's ability to "think" and process information in ways eerily similar to humans. It's no longer just about algorithms; it's about creating synthetic

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Crypto’s Moment of Truth

Source Node:
Time Stamp: July 1, 2023 9:27 AM - Modified On: July 1, 2023 - Published By:
Source Cluster:
Republished By Plato

In a pivotal moment for crypto, recent news that BlackRock and others such as Fidelity have filed for spot Bitcoin ETFs propelled BTC to a yearly high of just under $31,700. What does the arrival of these significant players mean for the future of crypto? For years, the prospect of a Bitcoin ETF approval in the United States has been shrouded in uncertainty. However, the tides are turning this time, as the involvement of industry giants like BlackRock hints at a higher likelihood of approval. Deniz, our CEO, echoes this

Rocket Raccoon: A Phenomenon of Memecoin Magic and the Pursuit of Financial Liberation

Source Node:
Time Stamp: May 19, 2023 4:16 PM - Modified On: May 19, 2023 - Published By:
Source Cluster:
Republished By Plato

In the ever-evolving world of cryptocurrencies, a remarkable phenomenon has captured the imagination of both seasoned investors and enthusiasts alike. This captivating tale revolves around the rise of a viral memecoin, where a charismatic raccoon character named Rocket has taken centre stage. Welcome to the intriguing world of Degen RocketRacoon. Drawing inspiration from the Marvel Cinematic Universe, particularly the beloved Guardians of the Galaxy franchise, Degen RocketRacoon seeks to deliver an electrifying rush that crypto investors crave. Despite its stealthy launch, this audacious project has swiftly captured public attention, boasting